Journal
DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 64, Issue 3, Pages 225-228Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2003.11.007
Keywords
metformin; type 2 diabetes mellitus; carotid artery; atherosclerosis
Categories
Ask authors/readers for more resources
To investigate the anti-atherogenic effect of metformin, we prospectively evaluated the effect of metformin treatment on common carotid intima-media thickness (CCA-IMT) in patients with type 2 diabetes. A 2-year open prospective study was performed. Thirty-six patients were treated with metformin (500-750 mg per day). CCA-IMT was measured after 1- and 2-year treatment. Changes in CCA-IMT were compared with control patients. After 2-year metformin therapy, the progression of CCA-IMT was significantly less than 56 control patients (0.02 +/- 0.08 mm versus 0.07 +/- 0.08 mm, P < 0.01). Metformin therapy did not alter body weight, blood pressure, HbA1c, and serum lipids relative to the control. Thus, metformin attenuates the progression of CCA-IMT. This anti-atherogenic effect is not mediated through changes in classical cardiovascular risk factors. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available